We have multiple, defensive utility patents filed on our ground-breaking breeding techniques, made possible and substantiated by advanced genomic mapping. Our work cannot be copied or “improved,” as our mother plants and pollen donors are not publicly available and will not ever be released–the seed we sell are as close to true F1s available to cannabis farmers. Unlike the many fly-by-night polyhybrid seed vendors that emerge each year in the hemp space, our established varieties are the result of repeated inbreeding (to the point of sterility) to reduce heterozygosity and lock-in specific traits before targeted outcrossing. This approach requires about 3 years of R&D between initial line design to commercial deployment, as the seed we sell to the public undergoes extensive field trials before release to ensure that it meets our rigorous standards of excellence. We are in this industry for the long haul and are devoted to making pure varieties containing novel cannabinoids (CBD, CBG, CBC, CBDV, CBGV, CBCV, etc.) available to farmers everywhere–our reputation means much more than a quick buck and we give priority to our returning clients when releasing new compounds.